Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment

Hormone Research

Volumn 64, Issue 2, 2005, Pages 77-87

  Visser Van Balen, Hanneke ^a,b   Geenen, Rinie ^b   Moerbeek, Mirjam ^b   Stroop, Rutger ^a   Kamp, Gerdine A ^c   Huisman, Jaap ^d   Wit, Jan M ^e   Sinnema, Gerben ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Gooi Noord Hospital   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gonadotropin releasing hormone agonist; Growth hormone; Idiopathic short stature; Psychological adaptation; Small for gestational age

Indexed keywords

GONADORELIN AGONIST; RECOMBINANT GROWTH HORMONE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GESTATIONAL AGE; HEALTH; HUMAN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SHORT STATURE; SOCIAL PSYCHOLOGY; TRAINING;

ADOLESCENT; ANXIETY; BODY HEIGHT; FEMALE; GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; PARENTS; PSYCHOMETRICS; SCHOOLS; SELF CONCEPT; SOCIAL BEHAVIOR; SPORTS; TREATMENT OUTCOME;

EID: 26444483444     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087700     Document Type: Article

References (52)

1. Ranke MB: Towards a consensus on the definition of idiopathic short stature. Horm Res 1996;45(suppl 2):64-66.
2. Rekers-Mombarg LT, Massa GG, Wit JM, Matranga AM, Buckler JM, Butenandt O, Chaussain JL, Frisch H, Leiberman E, Yturriaga R, Aarskog D, Chatelain PG, Colle M, Dacou-Voutetakis C, Delemarre-van de Waal HA, Girard F, Gosen JJ, Irle U, Jansen M, Jean R, Job JC, Kaar ML, Kollemann F, Lenko HL, Waelkens JJ, et al: Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators. J Pediatr 1998;132:455-460.
3. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M: Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr 1994;125:196-200.
4. Wit JM, Kamp GA, Rikken B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
5. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH: Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab 1998;83:1075-1079.
6. Hintz RL, Attie KM, Baptista J, Roche A: Effect of growth hormone treatment on adult height of children with idiopathic short stature: Genentech Collaborative Group. N Engl J Med 1999;340:502-507.
7. Wit JM, Rekers-Mombarg LT: Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 2002;87:604-611.
8. Chatelain P: Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul 2000;34:33-36.
9. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A: Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 2003;88:3584-3590.
10. Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM: High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 2002;87:215-220.
11. Balducci R, Toscano V, Mangiantini A, Municchi G, Vaccaro F, Picone S, Di Rito A, Boscherini B: Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab 1995;80:3596-3600.
12. Job JC, Toublanc JE, Landier F: Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm Res 1994;41:177-184.
13. Lanes R, Gunczler P: Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Clin Endocrinol (Oxf) 1998;49:197-202.
14. Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Hibi I: GH and GnRH analog treatment in children who enter puberty at short stature. J Pediatr Endocrinol Metab 1997;10:623-628.
15. Pasquino AM, Pucarelli I, Roggini M, Segni M: Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J Clin Endocrinol Metab 2000;85:619-622.
16. Saggese G, Cesaretti G, Barsanti S, Rossi A: Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls. J Pediatr 1995;126:468-473.
17. Mul D, Oostdijk W, Waelkens JJ, Schulpen TW, Drop SL: Gonadotrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty. Clin Endocrinol (Oxf) 2001;55:121-129.
18. Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frolich M, Oostdijk W, Wit JM: A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab 2001;86:2969-2975.
19. Kaplowitz PB: Editorial: If Gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what? J Clin Endocrinol Metab 2001;86:2965-2968.
20. Brooks-Gunn J: Antecedents and consequences of variations in girls maturational timing. J Adolesc Health Care 1988;9:365-373.
21. Alsaker FD: Annotation: The impact of puberty. J Child Psychol Psychiatry Allied Discip 2003;37:249-258.
22. Graber JA, Lewinsohn PM, Seeley JR, Brooks-Gunn J: Is psychopathology related to timing of pubertal development? J Am Acad Child Adolesc Psychiatry 1997;36:168-176.
23. Ge X, Conger RD, Elder GHj: The relationship between pubertal transition and psychological distress among adolescent boys. J Res Adolesc 2001;11:49-70.
24. Mul D, Versluis-den Bieman HJ, Slijper FM, Oostdijk W, Waelkens JJ, Drop SL: Psychological assessments before and after treatment of early puberty in adopted children. Acta Paediatr 2001;90:965-971.
25. Lundgren EM, Cnattingius S, Jonsson B, Tuvemo T: Intellectual and psychological performance in males born small for gestational age. Horm Res 2003;59(suppl 1):139-141.
26. van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC: Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. J Clin Endocrinol Metab 2004;89:5295-5302.
27. van der Reijden-Lakeman I, Slijper FM, van Dongen-Melman JE, de Waal WJ, Verhulst FC: Self-concept before and after two years of growth hormone treatment in intrauterine growth-retarded children. Horm Res 1996;46: 88-94.
28. Lundgren M, Cnattingius S, Jonsson B, Tuvemo T: Intellectual performance in young adult males born small for gestational age. Growth Horm IGF Res 2004;14(suppl A):S7-S8.
29. Huisman J: Medisch-psychologische bijdragen aan nieuwe behandelingswijzen in de kindergeneeskunde (The contribution of behavioral medicine to interventions in pediatrics); PhD thesis, Free University, Amsterdam, 1993.
30. Verhulst FC, Van der Ende J, Koot HM: Handleiding voor de CBCL 4-18 (Manual for the Child Behavior Check List). Assen/Maastricht, Van Gorcum, 1996.
31. Grew RS, Stabler B, Williams RW, Underwood LE: Facilitating patient understanding in the treatment of growth delay. Clin Pediatr (Phila) 1983;22:685-690.
32. Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, Cassorla FG, Quigley CA, Crowe BJ, Roberts K, Cutler GB Jr: Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab 2004;89:4873-4878.
33. Veerman JW, Straathof MAE, Treffers PDA, van den Bergh BRH, ten Brink LT: Handleiding bij de Competentie Belevingsschaal voor Kinderen, CBSK (Manual of the Self Perception Profile for Children - Dutch version). Amsterdam, Lisse, Swets & Zeitlinger, 1997.
34. Treffers PDA, Goedhart AW, Veerman JW, Van den Bergh BRH, Ackaert L, Rycke L: Competentiebelevingsschaal voor adolescenten (CBSA), handleiding (Manual of the Serf perception Profile for Adolescents - Dutch version). Amsterdam. Lisse, Swets & Zeitlinger, 2002.
35. Bakker FC, Van Wieringen PCW, Van der Ploeg HM, Spielberger CD: Handleiding bij de Zelf-Beoordelings-Vragenlijst voor kinderen, ZBV-K (Manual of the Stait-Trait Anxiety for children - Dutch version). Amsterdam, Lisse, Swets & Zeitlinger, 1989.
36. de Wit CAM: Handleiding bij de depressievragenlijst voor kinderen, DVK en KDVK (Manual of the short depression questionnaire for children - Dutch version). Amersfoort/Leuven, Acco, 2001.
37. Luteijn F, van Dijk H, van der Ploeg FAE: Handleiding bij de Junior Nederlandse Persoonlijkheidsvragenlijst, NPV-J (Manual of the Dutch Personality Questionnaire - junior). Lisse, Swets & Zeitlinger, 1989.
38. Maas CJM, Snijders TAB: The multilevel approach to repeated measures with missing data. Using multilevel software to obtain estimates and tests for the Manova model with possible incomplete data. Qual Quant 2002;37:71-89.
39. Hedeker D, Gibbons RD: MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comput Meth Programs Biomed 1996;49:229-252.
40. Hedeker D, Gibbons RD: MIXOR: a computer program for mixed-effects ordinal regression analysis. Comput Meth Programs Biomed 1996;49:157-176.
41. Hedeker D: MIXNO: a computer program for mixed-effects nominal logistic regression. J Stat Software 1999;4:1-92.
42. Cohen J: A power primer. Psychol Bull 1992;112:155-159.
43. Visser-van Baien H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G: Motives for choosing growth-enhancing hormone treatment in adolescents with idiopathic short stature: a questionnaire and structured interview study. BMC Pediatr 2005;5:15.
44. Stabler B, Frank NC: Quality of life and the psychiatric status of individuals treated with growth hormone in childhood; in Drotar D (ed): Measuring Health-Related Quality of Life in Children and Adolescents: Implications for Research and Practice. Mahwah, Lawrence Erlbaum Associates, 1998, pp 273-286.
45. Downie AB, Mulligan J, McCaughey ES, Stratford RJ, Betts PR, Voss LD: Psychological response to growth hormone treatment in short normal children. Arch Dis Child 1996;75:32-35.
46. Rekers-Mombarg LT, Busschbach JJ, Massa GG, Dicke J, Wit JM: Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr 1998;87:865-870.
47. Boulton TJ, Dunn SM, Quigley CA, Taylor JJ, Thompson L: Perceptions of self and short stature: effects of two years of growth hormone treatment. Acta Paediatr Scand Suppl 1991;377:20-28.
48. Theunissen NC, Kamp GA, Koopman HM, Zwinderman KA, Vogels T, Wit JM: Quality of life and self-esteem in children treated for idiopathic short stature. J Pediatr 2002;140:507-515.
49. Dubas JS, Graber JA, Peterson AC: The effects of pubertal development on achievement during adolescence. Am J Educ 1991;99:444-460.
50. Kroger J: Identity development: adolescence through adulthood. Thousand Oaks, Sage, 2000.
51. Harter S: The Construction of the Self: A Developmental Perspective. New York, The Guilford Press, 1999.
52. Sandberg DE, Meyer-Bahlburg HF, Yager TJ: The Child Behavior Checklist nonclinical standardization samples: should they be utilized as norms? J Am Acad Child Adolesc Psychiatry 1991;30:124-134.